Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report

被引:4
|
作者
MacLean, Alyssa [1 ]
Churg, Andrew [2 ,3 ]
Johnson, Scott Thomas [4 ,5 ]
机构
[1] Univ Alberta, Dept Surg, Div Gen Surg, Edmonton, AB, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC, Canada
[4] Univ Alberta, Dept Surg, Div Thorac Surg, Edmonton, AB, Canada
[5] Univ Alberta, Dept Surg, Div Thorac Surg, 415 CSC,10240 Kingsway Ave, Edmonton, AB T5H 3V9, Canada
来源
JTO CLINICAL AND RESEARCH REPORTS | 2022年 / 3卷 / 08期
关键词
Mesothelioma in situ; BAP1; Case report; Bilateral;
D O I
10.1016/j.jtocrr.2022.100356
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mesothelioma in situ is a recently described precursor to invasive mesothelioma. Thus far, all cases in the literature have involved one pleural cavity or the peritoneal cavity. We describe a patient with biopsy-proven mesothelioma in situ involving both pleural cavities and the peritoneal cavity. Genetic analysis results revealed that the patient had a BAP1 germline mutation. This is the first report of mesothelioma in situ involving multiple body cavities and raises a question of whether such patients will all have BAP1 germline mutations.(c) 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer. This is an open access article under the CC BY-NC-ND li-cense (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma
    Cheung, Mitchell
    Talarchek, Jacqueline
    Schindeler, Karen
    Saraiva, Eduardo
    Penney, Lynette S.
    Ludman, Mark
    Testa, Joseph R.
    CANCER GENETICS, 2013, 206 (05) : 206 - 210
  • [42] BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma
    McGregor, Stephanie M.
    Dunning, Ryan
    Hyjek, Elizabeth
    Vigneswaran, Wickii
    Husain, Aliya N.
    Krausz, Thomas
    HUMAN PATHOLOGY, 2015, 46 (11) : 1670 - 1678
  • [43] Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a BAP1 mutation
    Lee, Jimmy
    Turetsky, Jordan
    Nasri, Elham
    Rogers, Sherise C.
    BMJ CASE REPORTS, 2023, 16 (12)
  • [44] A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma
    Kinoshita, Yoshiaki
    Hida, Tomoyuki
    Hamasaki, Makoto
    Matsumoto, Shinji
    Sato, Ayuko
    Tsujimura, Tohru
    Kawahara, Kunimitsu
    Hiroshima, Kenzo
    Oda, Yoshinao
    Nabeshima, Kazuki
    CANCER CYTOPATHOLOGY, 2018, 126 (01) : 54 - 63
  • [45] MALIGNANT MESOTHELIOMA AND GERMLINE HETEROZYGOUS BAP1 MUTATION IN A YOUNG WOMAN PRESENTING WITH RECURRENT PLEURAL EFFUSIONS AND WORSENING PNEUMOTHORAX AFTER TALC PLEURODESIS
    Luk, Eric
    Kute, Blakely
    CHEST, 2020, 158 (04) : 1438A - 1438A
  • [46] Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours
    Yoshimura, Masayo
    Kinoshita, Yoshiaki
    Hamasaki, Makoto
    Matsumoto, Shinji
    Hida, Tomoyuki
    Oda, Yoshinao
    Nabeshima, Kazuki
    HISTOPATHOLOGY, 2017, 71 (06) : 1011 - 1014
  • [47] Diagnostic utility of BAP1 for malignant pleural mesothelioma in pleural fluid specimens with atypical morphology
    Louw, Amber
    Lee, Y. C. Gary
    Acott, Nathan
    Creaney, Jenette
    Vliet, Chris
    Chai, Siaw Ming
    CYTOPATHOLOGY, 2022, 33 (01) : 84 - 92
  • [48] BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
    Shrestha, Raunak
    Nabavi, Noushin
    Lin, Yen-Yi
    Mo, Fan
    Anderson, Shawn
    Volik, Stanislav
    Adomat, Hans H.
    Lin, Dong
    Xue, Hui
    Dong, Xin
    Shukin, Robert
    Bell, Robert H.
    McConeghy, Brian
    Haegert, Anne
    Brahmbhatt, Sonal
    Li, Estelle
    Oo, Htoo Zarni
    Hurtado-Coll, Antonio
    Fazli, Ladan
    Zhou, Joshua
    McConnell, Yarrow
    McCart, Andrea
    Lowy, Andrew
    Morin, Gregg B.
    Chen, Tianhui
    Daugaard, Mads
    Sahinalp, S. Cenk
    Hach, Faraz
    Le Bihan, Stephane
    Gleave, Martin E.
    Wang, Yuzhuo
    Churg, Andrew
    Collins, Colin C.
    GENOME MEDICINE, 2019, 11 (1)
  • [49] Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health
    Vimercati, Luigi
    Cavone, Domenica
    Fortarezza, Francesco
    Delfino, Maria Celeste
    Ficarella, Romina
    Gentile, Angela
    De Palma, Angela
    Marulli, Giuseppe
    De Maria, Luigi
    Caporusso, Concetta
    Marzullo, Andrea
    d'Amati, Antonio
    Romano, Daniele Egidio
    Caputi, Antonio
    Sponselli, Stefania
    Serio, Gabriella
    Pezzuto, Federica
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
    Raunak Shrestha
    Noushin Nabavi
    Yen-Yi Lin
    Fan Mo
    Shawn Anderson
    Stanislav Volik
    Hans H. Adomat
    Dong Lin
    Hui Xue
    Xin Dong
    Robert Shukin
    Robert H. Bell
    Brian McConeghy
    Anne Haegert
    Sonal Brahmbhatt
    Estelle Li
    Htoo Zarni Oo
    Antonio Hurtado-Coll
    Ladan Fazli
    Joshua Zhou
    Yarrow McConnell
    Andrea McCart
    Andrew Lowy
    Gregg B. Morin
    Tianhui Chen
    Mads Daugaard
    S. Cenk Sahinalp
    Faraz Hach
    Stephane Le Bihan
    Martin E. Gleave
    Yuzhuo Wang
    Andrew Churg
    Colin C. Collins
    Genome Medicine, 11